Antidepressants and pain

被引:308
作者
Mico, Juan A.
Ardid, Denis
Berrocoso, Esther
Eschalier, Alain
机构
[1] Univ Cadiz, Pharmacol & Neurosci Res Grp, Dept Neurosci Pharmacol & Psychiat, Sch Med, Cadiz 11003, Spain
[2] Univ Clermont 1, Dept Med Pharmacol, Fac Med, F-63001 Clermont Ferrand, France
[3] INSERM U 766, F-63001 Clermont Ferrand, France
[4] CHU Clermont Ferrand, Dept Pharmacol, Hop G Montpied, F-63003 Clermont Ferrand, France
关键词
D O I
10.1016/j.tips.2006.05.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tricyclic antidepressants, together with anticonvulsants, are considered to be first-line drugs for the treatment of neuropathic pain. Antidepressants are analgesic in patients with chronic pain and no concomitant depression, indicating that the analgesic and antidepressant effects occur independently. The analgesia induced by these drugs seems to be centrally mediated but consistent evidence also indicates a peripheral site of action. Several pharmacological mechanisms account for their antinociceptive effect but the inhibition of monoamine transporters (and, consequently, the facilitation of descending inhibition pain systems) is implicated on the basis of mechanistic and knockout-mouse studies. However, pain is a common symptom of depression, and depression is frequent in chronic pain patients, supporting the hypothesis that pain and depression share some common biochemical mechanisms. We suggest that antidepressants have a genuine analgesic effect and that research into their mechanisms of action will help to facilitate the development of new drugs.
引用
收藏
页码:348 / 354
页数:7
相关论文
共 74 条
[1]   Fluoxetine attenuates thermal hyperalgesia through 5-HT1/2 receptors in streptozotocin-induced diabetic mice [J].
Anjaneyulu, M ;
Chopra, K .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 497 (03) :285-292
[2]  
[Anonymous], 2006, WALL MELZACKS TXB PA
[3]  
Ansari A, 2000, HARVARD REV PSYCHIAT, V7, P257
[4]   ROLE OF CALCIUM CHANNELS IN EFFECTS OF ANTIDEPRESSANT DRUGS ON RESPONSIVENESS TO PAIN [J].
ANTKIEWICZMICHALUK, L ;
ROMANSKA, I ;
MICHALUK, J ;
VETULANI, J .
PSYCHOPHARMACOLOGY, 1991, 105 (02) :269-274
[5]   Potentiation of the antinociceptive effect of clomipramine by a 5-ht1A antagonist in neuropathic pain in rats [J].
Ardid, D ;
Alloui, A ;
Brousse, G ;
Jourdan, D ;
Picard, P ;
Dubray, C ;
Eschalier, A .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 132 (05) :1118-1126
[6]   INVOLVEMENT OF BULBOSPINAL PATHWAYS IN THE ANTINOCICEPTIVE EFFECT OF CLOMIPRAMINE IN THE RAT [J].
ARDID, D ;
JOURDAN, D ;
MESTRE, C ;
VILLANUEVA, L ;
LEBARS, D ;
ESCHALIER, A .
BRAIN RESEARCH, 1995, 695 (02) :253-256
[7]   Explaining high rates of depression in chronic pain: A diathesis-stress framework [J].
Banks, SM ;
Kerns, RD .
PSYCHOLOGICAL BULLETIN, 1996, 119 (01) :95-110
[8]   DIFFERENTIAL EFFECT OF DESIPRAMINE AND 2-HYDROXYDESIPRAMINE ON DEPOLARIZATION-INDUCED CALCIUM-UPTAKE IN SYNAPTOSOMES FROM RAT LIMBIC SITES [J].
BEAUCHAMP, G ;
LAVOIE, PA ;
ELIE, R .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 1995, 73 (05) :619-623
[9]   EFFECTS OF CHLOMIPRAMINE AND FLUOXETINE ON SUBCUTANEOUS CARRAGEENAN-INDUCED INFLAMMATION IN THE RAT [J].
BIANCHI, M ;
ROSSONI, G ;
SACERDOTE, P ;
PANERAI, AE ;
BERTI, F .
INFLAMMATION RESEARCH, 1995, 44 (11) :466-469
[10]   Pain-like behaviours in animals - how human are they? [J].
Blackburn-Munro, G .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (06) :299-305